Recursion Pharmaceuticals, Inc. Class A Common Stock
RXRX Real Time Price USDRecent trades of RXRX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by RXRX's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
Estimated quarterly lobbying spending
RXRX Revenue by Segment or Geography
New patents grants
-
Patent Title: Systems and methods for evaluating query perturbations Dec. 17, 2024
-
Patent Title: Utilizing masked autoencoder generative models to extract microscopy representation autoencoder embeddings Oct. 15, 2024
-
Patent Title: Utilizing masked autoencoder generative models to extract microscopy representation autoencoder embeddings Oct. 15, 2024
-
Patent Title: Utilizing machine learning and digital embedding processes to generate digital maps of biology and user interfaces for evaluating map efficacy Sep. 03, 2024
-
Patent Title: Utilizing machine learning and digital embedding processes to generate digital maps of biology and user interfaces for evaluating map efficacy Aug. 27, 2024
-
Patent Title: Methods of performing animal research Jul. 02, 2024
-
Patent Title: Preemptible-based scaffold hopping Jun. 18, 2024
-
Patent Title: Systems and methods for high throughput compound library creation Jun. 11, 2024
-
Patent Title: Heterocyclic compounds and related methods Mar. 05, 2024
-
Patent Title: Systems and methods for high throughput compound library creation Oct. 17, 2023
-
Patent Title: Preemptible-based scaffold hopping Jul. 18, 2023
-
Patent Title: Electronic monitor for experimental animals Mar. 28, 2023
-
Patent Title: Preemptible-based scaffold hopping Nov. 15, 2022
-
Patent Title: Device and method of measuring animal urine Jul. 26, 2022
-
Patent Title: Systems and methods for high throughput compound library creation Jul. 19, 2022
-
Patent Title: Techniques for analyzing and detecting executional artifacts in microwell plates Jun. 14, 2022
-
Patent Title: Method of measuring efficacy of treatment for an autoimmune disease in vivarium animals Sep. 07, 2021
-
Patent Title: Animal running wheel Aug. 17, 2021
-
Patent Title: Apparatuses containing an emulsion and methods of manufacture Jun. 15, 2021
-
Patent Title: Experimental animal behavioral research methods and apparatuses Mar. 30, 2021
-
Patent Title: Electronic monitor for experimental animals Feb. 16, 2021
-
Patent Title: Ordered picklist for liquid transfer Aug. 11, 2020
-
Patent Title: Systems and methods for discriminating effects on targets May. 07, 2019
-
Patent Title: Systems and methods for evaluating whether perturbations discriminate an on target effect Dec. 04, 2018
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to RXRX
Recent picks made for RXRX stock on CNBC
ETFs with the largest estimated holdings in RXRX
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $RXRX stock a Buy, Sell, or Hold?
- What is the price target for $RXRX stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $RXRX stock?
- Who owns the most shares of $RXRX stock?
- What funds own $RXRX stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view RXRX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.